HomeInvestors HealthAstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy... AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition (AZN:NASDAQ) By BOMAR ENT. March 17, 2025 FacebookTwitterPinterestWhatsApp Roland Magnusson EsoBiotec SA has entered into a definitive agreement to be acquired by AstraZeneca (NASDAQ:AZN) for up to $1 billion, on a cash and debt-free basis, it said on Monday. The deal includes an initial payment of $425 million on closing, and up Source link Previous articleBeating the StreetNext articleKnit Socks!: 17 Classic Patterns for Cozy Feet latest articles explore more Investing Habits: A Beginner’s Guide to Growing Stock Market Wealth Rover’s Weekly Market Brief – 01/02/2026 The Irish Investors’ Guidebook: The Definitive Guide to Investing in Ireland Options Trading Simplified: Beginner’s Guide to Make Money Trading Options in 7 Days or Less! – Learn the Fundamentals and Profitable Strategies of Options... Small Cap Breakout Stocks Guide: How to Spot Early Leaders and Capture High Growth Opportunities (The Investing Essentials Library) I’m 61 and Want a Divorce, but I Worry About My Finances. Should We Live Separately but Stay Married? LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
